Showing results (161-170 of 224) with videos related to
Sort By:
Pageof 23
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing SarcomaLillian M Guenther, Neekesh V Dharia, Linda Ross, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.British Journal of Cancer|March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.British Journal of Cancer|August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.Cancer|July 2, 2026
Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor StudyDuncan C Ramsey, David S Shulman, Grace C Zhou, et al.Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.Cancer Research|March 31, 2011
Differentiation of NUT midline carcinoma by epigenomic reprogrammingBrian E Schwartz, Matthias D Hofer, Madeleine E Lemieux, et al.JCO Precision Oncology|September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)Margaret E Macy, Rajen Mody, Joel M Reid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2017
Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology GroupAllison F O'Neill, Alexander J Towbin, Mark D Krailo, et al.Pageof 23